Back

Genotype-phenotype correlations with late gadolinium enhancement patterns in primary cardiomyopathy

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Phenotyping in dilated cardiomyopathy Dilated Cardiomyopathy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Maria Rita Lima

Hospital Santa Cruz, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Enhanced detection of titin-specific ecg features in dilated cardiomyopathy using a deep neural network analysis
Ms A. Heymans (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Heart failure in dilated/arrhythmogenic cardiomyopathy: insights from the SHaRe cohort
Doctor A. Fornaro (Florence, IT)
Abstract Slides Video
Presentation thumbnail
Prevalence and outcomes of ischaemic versus non-ischaemic dilated cardiomyopathy: an 18-year population-wide retrospective cohort study in Australia
Miss A. Jeon (Hornsby, AU)
Abstract Slides Video
Presentation thumbnail
Clustering in dilated cardiomyopathy at initial evaluation: an effective tool for clinical stratification
Doctor M. Perotto (Trieste, IT)
Abstract Slides Video
Presentation thumbnail
Sex-specific differences in the exposure and risk prediction of life-threatening arrhythmias in dilated cardiomyopathy with available genetic information
Doctor M. Gigli (Trieste, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Phenotyping in dilated cardiomyopathy

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Genotype-phenotype correlations with late gadolinium enhancement patterns in primary cardiomyopathy
thumbnail
Congress Presentation
Gene-echocardiography: refining genotype-phenotype correlations in cardiomyopathy patients with restrictive phenotype
thumbnail
Congress Presentation
Overlap in scarring phenotypes between non-dilated left ventricular cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: Implications for prognostic stratification

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources